MKI67 and small intestine neuroendocrine neoplasm: This study aimed to evaluate the clinicopathological features and prognostic markers in patients diagnosed with small bowel neuroendocrine tumors (SB-NETs), with a specific focus on lymph node and liver metastases, Ki-67 proliferation index, and treatment outcomes.